MEDESIS PHARMA S.A.

Highlights Medesis Pharma S.A.

Equities

ALMDP

FR0010844464

Real-time Euronext Paris Other stock markets 10:24:42 14/05/2024 BST			5-day change	1st Jan Change
1.33 ^EUR	-1.12%		-0.37%	+53.23%

2023	Medesis Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	MEDESIS : Invest Securities confirms its recommendation	CF

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Medesis Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	27/10/23	CI
MEDESIS : Invest Securities confirms its recommendation	06/10/23	CF
MEDESIS : Invest Securities confirms its recommendation	07/07/23	CF
Medesis Pharma Up 65% After Asking Funds For Nuclear Contamination Drugs	05/04/22	MT
Medesis Pharma Publishes an Information Note on the Three Future Drugs in Development for the Protection of Large Populations Contaminated After A Civil or Military Nuclear Accident	05/04/22	CI
Medesis Pharma Wins COVID-19 Drug Trial Approval In Brazil	22/11/21	MT
Global markets live: Nvidia, Microsoft, Dell, Apple, Uber...	27/08/21
Medesis Pharma S.A. has completed an IPO in the amount of €7.350317 million.	09/02/21	CI
Medesis Pharma S.A. has filed an IPO in the amount of €7.350317 million.	26/01/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer